4//SEC Filing
THURMAN RANDY H 4
Accession 0001415889-24-024701
CIK 0001649989other
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 8:30 PM ET
Size
8.5 KB
Accession
0001415889-24-024701
Insider Transaction Report
Form 4
THURMAN RANDY H
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-10-01+89,549→ 89,549 totalExercise: $5.22Exp: 2034-10-01→ Common Stock (89,549 underlying) - Award
Stock Option (Right to Buy)
2024-10-01+56,636→ 56,636 totalExercise: $5.22Exp: 2034-10-01→ Common Stock (56,636 underlying)
Footnotes (2)
- [F1]This option grant is an annual stock option grant under the Issuer's Non-Employee Director Compensation Policy and the Issuer's 2024 Equity Incentive Plan (the "2024 Plan") and shall fully vest on October 1, 2025, subject to the Reporting Person providing continuous service to the Issuer on such date. In addition, the shares underlying the options are subject to acceleration upon a Change in Control as defined in the 2024 Plan, subject to the Reporting Person providing continuous service to the Issuer immediately prior to such Change in Control.
- [F2]This option grant was made under the 2024 Plan and shall fully vest on October 1, 2025, subject to the Reporting Person providing continuous service to the Issuer on such date. In addition, the shares underlying the options are subject to acceleration upon a Change in Control as defined in the 2024 Plan, subject to the Reporting Person providing continuous service to the Issuer immediately prior to such Change in Control.
Documents
Issuer
Outlook Therapeutics, Inc.
CIK 0001649989
Entity typeother
Related Parties
1- filerCIK 0001204059
Filing Metadata
- Form type
- 4
- Filed
- Oct 2, 8:00 PM ET
- Accepted
- Oct 3, 8:30 PM ET
- Size
- 8.5 KB